Abstract
Due to the good biocompatibility, ease of modification and unique optical properties, gold nanorods (AuNRs) have attracted more and more attentions in biomedical fields. In particular, through surface functionalization, AuNRs can be used as nano-carriers for drugs, probes, nucleic acids, and proteins in cancer treatment. In this review, we summarize the latest progress in biomedical applications of AuNRs-based nano-carriers including those in detection, biocatalysis, imaging, drug, and gene delivery. We also discuss the bioeffects of AuNRs such as in vivo distribution, translocation, localization, metabolism, and toxicity. Finally, we highlight some challenges in future biomedical applications of AuNRs-based nano-carriers.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
With the rapid development of imaging technology, the perspectives of biomedical research have turned from subcellular structures in micro-scale (chromosomes, organelles, cytoskeleton, etc.) to biomolecules in nano-scale (nucleic acids, proteins, etc.). Studies on how biomacromolecules assemble, coordinate, transmit signals, and execute function are very meaningful and important, because they can facilitate the research on nano-biointeractions and promote the progress in biological detection, diagnosis and treatment techniques. Nano-biomedicine mainly focuses on the bio-effects of nanomaterial and nanotechnology in biomedical applications, specifically, researching on the interaction between nanomaterial and biosystems, designing, and developing new type of nanomaterial according to its structure and property. The nanomaterial can be used as carriers of agents and information in the fields of biocatalysis, imaging and diagnosis, etc. Nano-carriers have many advantages when compared with traditional biological carriers, such as small size, large aspect ratio, ease to be modified with multiple functional molecules. They could significantly improve tissue and cell targeting, extend the circulation time and realize controllable release of biomolecules (DNA, siRNA) or drugs (Kim et al. 2012).
AuNRs are new precious metal nanomaterial with ease of preparation, controllable shape and size. They also have unique physical and chemical properties, such as surface-enhanced Raman scattering (SERS), surface plasmon resonance (SPR), two-photon luminescence (TPL), enhanced penetration and retention (EPR) effects, photothermal effects. Through surface modification, the multifunctional nano-complex can further expand applications of AuNRs in the fields of sensing and detection (le Tuyen et al. 2012; Sivashanmugan et al. 2013; Osberg et al. 2012; Hu et al. 2012; Komathi et al. 2013; Truong et al. 2012), biocatalysis (Zhou et al. 2012; Blankschien et al. 2012), imaging (Gui and Cui 2012; Dreaden and El-Sayed 2012; Ng et al. 2013; Zhu et al. 2012a; Zhang et al. 2012; Ju et al. 2013), drug and gene delivery (Tucker-Schwartz et al. 2012; Ramos and Rege 2012; Chu et al. 2013; Chakravarthy et al. 2010; Alkilany et al. 2012), hyperthermia (Gui and Cui 2012; Dreaden and El-Sayed 2012; Chakravarthy et al. 2010; Dreaden et al. 2012a, b) and multifunctional diagnose platform (Zhang et al. 2012; Ren et al. 2013). Various applications of AuNRs in biomedical fields are illustrated in Fig. 1. Herein, we will elaborate the functionalization, biomedical applications, and bio-effects of AuNRs-based nano-carriers, and discuss some difficulties and challenges in the future applications of AuNRs.
Modification and functionalization of AuNRs
AuNRs have been synthesized for several decades, and the seeded growth syntheses have attracted much attention in AuNRs optical properties and applications (Lohse and Murphy 2013). Surface modification of AuNRs is very essential to its stability and cytotoxicity (Kim et al. 2013). AuNRs synthesized in laboratory often have a layer of CTAB molecules on the surface, and the high concentration of salts in the biosystems could induce CTAB molecules to shed off, leading to aggregation. Surface functionalization could dramatically change the situation, it could alter surface properties of AuNRs, increase AuNRs stability in solution and improve the transmission of AuNRs in biosystems. Three general surface functionalization methods for AuNRs are presented in Fig. 2. For example, to modify AuNRs with compounds-containing mercapto group, for instance mercapto group-terminated poly(ethylene glycol) (PEG-SH), could form stable gold–sulfur ligand bond. It can effectively prevent the reunion of AuNRs, against non-specific adsorption of proteins. As a result, prolongs the circulation time in vivo and increases the accumulation of AuNRs at tumor site. Kim et al. (2010) studied on the plasmonic properties of 6-nm gold nanoparticles in 4-cyano-4-n-pentylbiphenyl (5CB), they found that the solubility was obviously enhanced after the surface capping material was changed to ligands that chemically resemble the liquid crystal molecules.
Electrostatic adsorption or layer-by-layer polyelectrolyte assembly is commonly used to functionalize AuNRs. Firstly, to adsorb anionic polyelectrolyte polystyrene sulfonate sodium (PSS) on positive-charged CTAB molecules, followed by adsorption with poly (diallyldimethyl ammonium chloride, PDDAC) (Chakravarthy et al. 2010). Compared with CTAB modification, PDDAC modification can obviously reduce toxicity of AuNRs, and increase cellular uptake of AuNRs remarkably (Qiu et al. 2010). Vigderman et al. functionalized AuNRs by complete exchange of CTAB with its thiolated analog (16-mercaptohexadecyl) trimethylammonium bromide (MTAB). Inductively coupled plasma-optical emission spectrometry (ICP-OES) showed that breast cancer cells (MCF-7) could uptake extremely large number of AuNRs (Vigderman et al. 2012). AuNRs can also be modified with specific surface groups and covalently linked with nucleic acids, proteins or other targeting ligands, such as RGD peptide (Oyelere et al. 2007; Xiao et al. 2012a), folic acid (FA) (Huang et al. 2011), delta enkephalin (Black et al. 2008), these modifications can also be further used in gene therapy (Yamashita et al. 2011).
Another strategy often used to functionalize AuNRs is physical modification by forming shell structure of mesoporous silica around AuNRs. Gorelikov and Matsuura (2008) reported the one-step synthesis they coated one thin layer of mesoporous silica around AuNRs. In the process of synthesis reaction, the CTAB molecule on the surface of AuNRs can be used as 3D polymerization reaction templates of tetraethyl orthosilicate (TEOS), which could contribute to the formation of mesoporous structure. High aspect ratio, large pore size, excellent biocompatibility, superior chemical and thermal stability, all of these features make mesoporous silica-coated AuNRs superior carriers for drug and gene delivery (Slowing et al. 2008; Xu et al. 2012). The layer of silicon dioxide could improve the dispersibility of AuNRs and reduce toxicity by shielding unstable and toxic CTAB molecules. So far, mesoporous silica-coated AuNRs have already been applied in biological imaging (Huang et al. 2011), hyperthermia (Chen et al. 2010a), drug and gene delivery (Chen et al. 2010b).
Biomedical applications of AuNRs-based nano-carriers
In recent years, development of new formulations of drugs and biological products based on nano-carriers has become an important trend in current research in nano-biomedical fields. Nanoparticles could carry and transport a variety of biomolecules and drugs including nucleic acids, polypeptides, proteins, radioactive substances, chemotherapeutic drugs, fluorescent probes, photosensitizers (Vigderman and Zubarev 2012), which show great prospects in early diagnosis and treatment (Dreaden et al. 2012a, b). Various biomedical applications of AuNRs-based nano-carriers are presented in Table 1. Meanwhile, AuNRs could achieve efficient drug loading, controllable drug release by stimulus of microenvironment or external physical stimulus (light, magnetism, ultrasound, heat, electricity) (Table 2). For example, sensitive response to acidic pH of tumor tissue or protease of organisms and the light-mediated remote control of drug release corresponding to dose and time show great value in future cancer therapy.
Carriers for biological detection
Based on the properties of SERS and SPR, AuNRs can be used as carriers for detection of proteins, nucleic acids and other molecules (Fig. 3). Lu et al. (2012) used the photoluminescence of plasmonic AuNRs to detect biotin–streptavidin-binding efficiency, the results indicated that the photoluminescence can provide an alternative way for label-free plasmonic sensing and the detection sensitivity was improved to a large extent. Zhu et al. (2013) investigated the spectroscopic-sensing of RNA folding, they found that the length of the RNA, AuNRs aspect ratio, large dielectric constant (DC) difference between RNA shell and environmental media were important factors affecting the sensitivity of detection. Spadavecchia et al. (2013) studied the detection of DNA hybridization using the plasmonic properties of AuNRs, the amplification results in a significant decrease of the limit of detection from 40 nM as observed for unlabeled DNA to 0.2 nM for labeled DNA molecules. Sun et al. (2012) used glucose oxidase (GOx)-modified AuNRs as label to study the sensitive electrochemical immunosensor for the detection of protein biomarker tumor necrosis factor α (TNF-α), the results showed that the immunosensor had higher sensitivity, wide linear range (0.005–10 ng/mL) and upstanding selectivity. Kim et al. designed a material strategy for a type of bio-interfaced system which relied on ultrathin electronics supported by bioresorbable substrates of silk fibroin. These concepts showed important opportunities for diagnosing and treating disease and for improving brain/machine interfaces (Kim et al. 2010).
However, owing to the complexity of biosystems, AuNRs confronts a lot of limitations in the fields of in vivo detection. SERS could detect a variety of spectral information which is very difficult to analyze. The repeat sequences of biomolecules could also lead to overlapping of information in SERS spectrum. In addition, because of the weak signal intensity of SERS, it usually takes long-point scan time to get better results. Therefore, it needs detailed analysis when detecting biomolecules (Willets 2009).
Carriers for biocatalysis
Insufficient coordination of surface atoms could lead to high surface energy and increase surface active sites, these characteristics are basic conditions for AuNRs as superior catalyst. Blankschien et al. reported the fabrication of light-responsive and thermophilic enzyme-photothermal AuNRs complex. They found that the enzyme can significantly improve the efficiency of glucose decomposition under light activation. The encapsulated nanocomplex turned out to be reusable and stable for several days, which makes AuNRs useful in industry and in the research on biochemical pathways (Blankschien et al. 2012). He et al. formed Au@Pt nanostructure by depositing Pt dots on the surface of AuNRs by transporting oxygen to the solution, and the Au@Pt could lead to the oxidation of vitamin C quickly. Because of the similar activity to oxidase, peroxidase, catalase, the nano-complex can also be used as catalyst in reduction reaction as well as decomposition reaction (He et al. 2011). The properties of low cost, high stability, small affect by reaction condition, adjustable enzyme activity (Fig. 3) make AuNRs very suitable for catalytic reaction especially for oxidation–reduction reaction.
Carriers for imaging
Various kinds of imaging can be achieved due to the superior properties of AuNRs (Fig. 4), including intracellular imaging, small animal imaging, and even unmarked imaging. Here, we expound applications of AuNRs-based nano-carriers with different imaging techniques.
Two-photon luminescence
The TPL imaging of AuNRs have been widely used in the imaging of cells, tissues, vicinal blood vessels of epidermis. Wang et al. used femtosecond pulse laser to irradiate AuNRs at wavelength of 830 nm. They found that the two-photon fluorescence intensity produced by AuNRs was 58 times higher than that produced by rhodamine. After injection of mice via the tail vein, the fluorescence intensity of AuNRs in the bloodstream was three times higher than the autofluorescence of blood vessels and tissues. These results suggested that AuNRs were very suitable for shallow tissue imaging with the good contrast (Wang et al. 2005). Durr et al. modified AuNRs with surface-specific adsorption of targeted antibodies, they successfully identified the surface receptor molecules of tumor cell and realized three-dimensional imaging of marked tumor cell (Durr et al. 2007). Zhang et al. developed a multi-mode optical imaging microscope, combined with the NIR irradiation, it could induce second harmonic generation (SHG), TPL, linear resonance light scattering with imaging of human skin cancer cells (Cao et al. 2012).
X-ray computed tomography
The X-ray CT is based on the difference of X-ray absorption coefficient at different parts of organism. As the conventional angiography molecule, iodine has high atomic weight and X-ray absorption coefficient, which is often used as contrast agent. However, such contrast agent can cause renal toxicity and could be excreted rapidly by the kidney, making scan time allowed very limited. AuNRs have higher absorption coefficient than iodine, super for bone and soft tissue imaging, can significantly reduce radiation dose and mitigate radiation damage to organism. AuNRs modified with PEG-SH have longer circulation time than iodine which could achieve visualization at molecular level by decorating AuNRs with targeting ligand against the biomarkers of specific diseases. Luo et al. reported that Au@SiO2 loaded with indocyanine green (ICG) could realize dual function of X-ray scanning and fluorescence imaging. Au@SiO2 could enhance the intensity of CT contrast agent and could help to obtain higher contrast images (Luo et al. 2011). Huang et al. synthesized FA-coated Au@SiO2 nano-complex, they located the tumor using X-ray tomography and established the integrated treatment platform with imaging and hyperthermia (Huang et al. 2011).
Photoacoustic tomography
PTA, similar to ultrasound imaging, is characterized by non-invasive optical imaging. PTA could also achieve deeper tissues detection than TPL. AuNRs have high optical absorption efficiency at wavelength near LSPR, after absorption of laser energy, acoustic shock generated by instantaneous high thermal and thermoelasticity expansion can be detected and converted into information in graphical form through scanning transducer. Wang et al. used AuNRs as photoacoustic imaging probes, by using the enhanced difference photoacoustic microscopy (PAM), they observed the spatial structure of blood–brain barrier in rat model (Wang et al. 2012). Neus et al. synthesized the liposome–AuNRs hybrids consisted of lipid-bilayer-associated AuNRs, they accomplished deep tissue detection, therapy and monitored the distribution in living animals (Lozano et al. 2012). Yang et al. observed the dynamic changes of intracellular AuNRs through optoacoustic imaging, the results demonstrated an successful application of PAM for complements to imaging of non-fluorescent nanoparticles (Yang et al. 2012).
Optical coherent tomography
OCT utilizes the technology of section scanning, and has similar principle with ultrasound imaging. When irradiate the spot at detection site, the phase difference of reflected wave in micro-structure at different depth can be measured by interferometer. The signal–noise ratio of traditional OCT is usually not high enough to achieve high-quality imaging, so researchers designed the core–shell structure of AuNRs to improve it (Zhang et al. 2012; Zhu et al. 2012a; Ng et al. 2013). Ju et al. recently investigated the photoacoustic cavitation for a broad range of ultrasound pressures and nanoparticle concentrations of AuNRs illuminated at wavelength of 724 nm. Results showed that photoacoustic cavitation can be produced at depth in biological tissue without exceeding the safety limits for ultrasound or laser radiation at tissue surface (Ju et al. 2013).
Carriers for hyperthermia
Traditional cancer treatments can cause damage to both normal and tumor cells along with liver and kidney toxicity, inducing hair loss, nausea, and loss of heart function. In general, radiation therapy could kill cancer cells effectively, but it can also cause damage to normal cells inevitably, inducing bone marrow suppression. The LSPR of AuNRs can be adjusted to near-infrared region, after irradiation by femtosecond pulse laser, the light energy absorbed by AuNRs can be rapidly converted into heat, and the large amount of heat are too late to release while causing AuNRs melting and deformation, and resulting in tumor cell membrane blebbing, enhancement of cell membrane permeability, denaturation of intracellular protein, loss of mitochondrial function, and eventually lead cancer cells to necrosis. Hyperthermia is usually achieved by the physical methods (microwave, electromagnetic field, ultrasound, water bath, hot perfusion) by changing local tumor microenvironment and organelle structure (Shen et al. 2013; Leung et al. 2013). In contrast, moderate hyperthermia can ease negative effects of traditional cancer treatments. Huang et al. conjugated AuNRs to anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies. When exposed to continuous red laser at wavelength of 800 nm, both efficient cancer cells diagnostics and selective photothermal therapy could be achieved at the same time (Huang et al. 2006).
Carriers for gene and protein delivery
With the purpose of treating and correcting defects of gene, gene therapy is usually achieved by importing normal human genes or genes that have therapeutic function into target cells by a certain way. But exogenous gene or small interfering RNA has low transfection efficiency and is very easy to be degradation by nuclease in the physiological environment, leading the half-life shortened. Viral vectors have high transfection efficiency, but may cause immune response or even lead to mutation. Therefore, gene transfection need for a safe and low toxicity vector to carry exogenous genes into cells. In recent years, researches on Au NR-based nano-carriers involved transportation of nucleic acids and proteins have attracted much attention. Because DNA and proteins could be modified easily on the surface of AuNRs, and can still maintain the function even after release.
Ramos and Rege synthesized poly(amino ether)-functionalized nano-complex (PAE–AuNRs) using a layer-by-layer deposition approach, and then binded with plasmid DNA by means of electrostatic interaction. The results indicated that the stable and effective PAE–AuNRs assemblies were promising engineered platform for transgene delivery (Ramos and Rege 2012). Chakravarthy et al. used AuNRs to deliver an innate immune activator to against type A influenza virus. They found the GNR-5′PPP-ssRNA nano-complex could activate the retinoic acid-inducible gene I (RIG-I) pathogen recognition pathway. Results suggested that further evaluation of biocompatible nano-complex as unique antivirals for treatment of seasonal and pandemic influenza viruses was warranted (Chakravarthy et al. 2010). Mahajan et al. (2012) designed the nanocomplex by electrostatically binding AuNRs with MMP-9 siRNA, the uptake of nano-complex by BMVEC cells can result in suppression of matrix metalloproteinase-9 (MMP-9) expression, and the nano-complex could also prevent the damage to BBB disruption induced by neuroinflammation. Kah et al. conjugated coronas of serum proteins on AuNRs, and then loaded AuNRs with DNA oligonucleotides and doxorubicin. These coronas can hold small molecular drugs at a capacity much higher (5–10 times) than covalent conjugation strategies can achieve (Kah et al. 2012). Xu et al. (2012) prepared surface-engineered AuNRs, which were used as promising DNA vaccine adjuvants for HIV treatment, they found PDDAC- or PEI-modified AuNRs can significantly promote cellular and humoral immunity as well as T-cell proliferation. These findings shed lights on the rational design of low-toxic nanomaterial as a versatile platform for vaccine nanoadjuvants delivery systems (Fig. 5).
Carriers for drug delivery
Although chemotherapeutic drugs play an important role in cancer treatment, they still have many disadvantages, such as large demand, significant side effects, non-specific targeting, susceptible to be discharged or even causing multidrug resistance. These shortcomings significantly limit their clinical applications. AuNRs could be used as nano-carriers of drugs, and release of drugs can be remotely controlled by external stimuli. Due to its advantages in highly flexible control of dosage and time, the use of light as remote-activation stimuli is worth considering.
Book Newell et al. coupled AuNRs with a targeting ligand, FA and DOX, they utilized multi-photon fluorescence lifetime imaging to monitor the uptake of AuNRs, release of drug and localization of AuNRs in living cells (Book Newell et al. 2012). Min et al. (2010) conjugated PEGylated AuNRs with Pt(IV) prodrug as drug delivery system, it showed superior cytotoxicity to different types of cancer cells compared to cisplatin. Xiao et al. linked DOX onto PEGylated AuNRs via a hydrazone bond to achieve pH-sensitive drug release, and then conjugated tumor-targeting ligands (i.e., the cyclo(Arg-Gly-Asp-d-Phe-Cys) peptides, cRGD) and 64Cu-chelators (i.e., 1,4,7-triazacyclononane-N,N′,N″-triacetic acid (NOTA)) onto the distal ends of the PEG arms to achieve active tumor-targeting and PET imaging. The results suggested that the multifunctional AuNRs-based nanoplatform can be optimized for combined cancer therapies (chemotherapy and thermotherapy) and multimodality imaging (PET, optical, X-ray CT) (Xiao et al. 2012a).
Combined function of AuNRs-based nano-carriers
Development theranostic systems in nano-scale for effective treatment of tumor have always been a popular trend in nano-biomedical research. By integrating diagnosis, imaging and treatment into one single nanoplatform, AuNRs could realize promising combined functions (Hu et al. 2013).
Carriers for imaging and hyperthermia
Charan et al. linked AuNRs with MUA (11-mercaptoundecanoic acid) and low-molecular-weight chitosan oligosaccharide (M w ∼5,000), and then conjugated with tumor targeting monoclonal antibody. The results demonstrated that CO–AuNRs could be a potential candidate for localized hyperthermia-based noninvasive imaging and photothermal-related therapies (Charan et al. 2012). Chen et al. (2013a) synthesized a novel nano-seaurchin structure through mesoporous silica-coated AuNRs, the nanoplatform provided stable photoacoustic signal and high efficient hyperthermia effect both in vitro and in vivo, and realize photoacoustic imaging and photothermal therapy simultaneously.
Carriers for hyperthermia and drug delivery
Combining hyperthermia with chemotherapeutic drugs could produce synergistic therapeutic effect toward tumor cells or even multidrug resistant cancer cells. Ren et al. loaded AuNRs with paclitaxel with high density (2.0 × 104 paclitaxel per AuNRs) via nonspecific adsorption. The combined photothermal therapy and chemotherapy was shown to be highly effective in killing head and neck cancer cells and lung cancer cells (Ren et al. 2013). Chen et al. synthesized multifunctional chitosan nanospheres which co-carried AuNRs and cisplatin, results showed that the nano-complex could produce local hyperthermia to an average temperature of 49 °C in tumor tissue after NIR irradiation for 10 min. Compared with chemotherapy or photothermal treatment alone, the combined photothermal therapy and chemotherapy had a significantly synergistic effect and improved the therapeutic efficacy (Chen et al. 2013b).
Carriers for imaging, hyperthermia, and drug delivery
In order to expand drug-loading capacity of AuNRs, surface modification such as modified with polymers or mesoporous structure usually be a good choice. Zhang et al. synthesized the multifunctional nano-carrier (Au@SiO2) loaded with DOX, they coated mesoporous silica structure around AuNRs, and the mesoporous silica can also be functioned as physical barrier to avoid AuNRs reunion. Owing to the controllable TPL imaging and unique LSPR property of AuNRs, it could realize imaging and hyperthermia through NIR irradiation, and the NIR irradiation could also be employed to control drug release. In the treatment options, NIR laser irradiation at a low intensity was used to realize imaging, and achieve temperature rising quickly to induce DOX release from Au@SiO2-DOX. While at a relatively high intensity, it could realize both hyperthermia effect of killing cancer cells and releasing DOX (Fig. 6).
Distribution, transportation, metabolism, and toxicity of AuNRs
Studies on the physical and chemical properties of AuNRs and understanding the mechanism of bio-nano-interaction will help to exert its function more efficient and safe. The distribution, transportation, metabolism, and toxicity of AuNRs are the major aspects of safety evaluation. Cellular uptake and toxicity of AuNRs are closely related to surface modification, aspect ratio, and cell types. Chen and Irudayaraj, for the first time, quantified the localization and evaluated the diffusion time of herceptin-conjugated AuNRs in different cell organelles by fluorescence correlation spectroscopy (FCS). They found that herceptin-conjugated AuNRs had similar intracellular localization as herceptin ErbB2 complex had (Chen and Irudayaraj 2009). Wang et al. studied on the interaction between AuNRs and different cell lines. They observed that AuNRs had distinct effects on cell viability via killing cancer cells while posing negligible impact on normal cells. This differed in cellular uptake, intracellular trafficking, and susceptibility of lysosome to AuNRs by different types of cells, which lead to the selective accumulation of AuNRs in the mitochondria of cancer cells (Wang et al. 2010a).
In addition, the removal of AuNRs also associated with its exposure pathways. AuNRs could easily be accumulated in the reticuloendothelial system through intravenous injection. However, AuNRs could be discharged in the form of feces when uptake of AuNRs by oral route. So researching on how to avoid being recognized by reticuloendothelial cells, decreasing non-specific accumulation while increasing the volume in target organs, are considerable challenges. When surface-modified AuNRs with PEG, it could reduce the non-specific adsorption of plasma proteins, prolong the circulation time in the blood. As a result, AuNRs accomplished its function through penetrating into the target tissues or cells by the EPR effect (Walkey et al. 2012; Akiyama et al. 2009). Huang et al. conjugated AuNRs to three different ligands of solid tumors, and then studied the targeted delivery of AuNRs. The results suggested that these targeting ligands could only marginally improve the total gold accumulation in xenograft tumor models in comparison with non-targeted controls, but could greatly alter the intracellular and extracellular nanoparticle distributions (Huang et al. 2010).
When researching on the bio-effects of AuNRs, researchers need to pay attention to different aspects, such as biomolecules, microenvironment, cells, tissues, organs, and individual level (Table 3). The methods include conventional characterization, spectroscopic analysis, structural analysis, quantitative analysis, conventional molecular and cell biology techniques, organization and pathological techniques, small animal imaging techniques, etc. All these methods could also provide mirrors for the researches on bio-effects to other metal nanomaterials.
Conclusions
AuNRs could absorb proteins in biological systems, thus forming protein–AuNRs nano-complex. These proteins could probably block functions of molecules modified on the surface of AuNRs, which in turn decreases the sensitivity of biological detection. Therefore, how to design suitable modification methods and exposure pathways to reduce the non-specific adsorption of proteins, achieve long blood circulation time, and eventually be cleared by the body, are problems to be resolved.
The bio-effects of AuNRs are complex processes. Researchers need dynamically monitor the behavior of AuNRs in vivo and in vitro, and focus on the long-term effects before achieving comprehensive biomedical applications. However, relevant systematic researches are very limited. Therefore, it is very necessary to carry on multi-faceted evaluation on bio-effects of AuNRs. The focuses should be extended from conventional cytotoxicity to the influence on immune system, respiratory system, cardiovascular system, and reproductive system.
Owing to limited light penetration depth in tissue, the applications of optical imaging techniques are still limited for AuNRs. How to combine deep imaging techniques (X-ray tomography imaging, magnetic resonance imaging, and body-embedded optical fiber), while achieving imaging and therapy simultaneously are still worth exploring. High-throughput screening combined with metal genomics (metal characterization and analytical methods) and biological genomics (biochips, proteomics) could help to evaluate and predict structure, performance, functionality of AuNRs systematically (Li et al. 2008).
In summary, AuNRs-based nano-carriers have great potential in biomedical fields, such as biological monitoring, imaging, thermotherapy and multifunctional nano-complex diagnose, and all these bring ideas and hopes to the development of biomedicine. In connection with structure, property and bio-effects of AuNRs, developing real-time, sensitive, high-throughput detection, and analysis methods could be the important consults to rational design of AuNRs-based nano-carriers. Ultimately, through surface modification and functionalization, it could improve targeting of AuNRs, reduce immune response and other negative effects, these AuNRs-based multifunctional nano-carriers will play crucial role in future biocatalysis, disease diagnosis, imaging and therapy.
References
Akiyama Y, Mori T, Katayama Y, Niidome T (2009) The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 139(1):81–84
Alkilany AM, Thompson LB, Boulos SP, Sisco PN, Murphy CJ (2012) Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 64(2):190–199
Black KC, Kirkpatrick ND, Troutman TS, Xu L, Vagner J, Gillies RJ, Barton JK, Utzinger U, Romanowski M (2008) Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agents. Mol Imaging 7(1):50–57
Blankschien MD, Pretzer LA, Huschka R, Halas NJ, Gonzalez R, Wong MS (2012) Light-triggered biocatalysis using thermophilic enzyme-gold nanoparticle complexes. ACS Nano 7(1):654–663
Book Newell B, Wang Y, Irudayaraj J (2012) Multifunctional gold nanorod theragnostics probed by multi-photon imaging. Eur J Med Chem 48:330–337. doi:10.1016/j.ejmech.2011.12.036
Cao C-J, Li D-R, Chen C-X, Yang X-Y, Hu J, Yang Y, Zhang C-Y (2012) Multimodal optical microscopy in combination with gold nanorods for cancer cell imaging. J Biomed Opt 17(12):126002
Chakravarthy KV, Bonoiu AC, Davis WG, Ranjan P, Ding H, Hu R, Bowzard JB, Bergey EJ, Katz JM, Knight PR (2010) Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc Natl Acad Sci USA 107(22):10172–10177
Charan S, Sanjiv K, Singh N, Chien F-C, Chen Y-F, Nergui NN, Huang S-H, Kuo CW, Lee T-C, Chen P (2012) Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation. Bioconjug Chem 23(11):2173–2182
Chen J, Irudayaraj J (2009) Quantitative investigation of compartmentalized dynamics of ErbB2 targeting gold nanorods in live cells by single molecule spectroscopy. ACS Nano 3(12):4071–4079
Chen Y-S, Frey W, Kim S, Homan K, Kruizinga P, Sokolov K, Emelianov S (2010a) Enhanced thermal stability of silica-coated gold nanorods for photoacoustic imaging and image-guided therapy. Opt Express 18(9):8867–8878
Chen Y, Chen H, Zeng D, Tian Y, Chen F, Feng J, Shi J (2010b) Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 4(10):6001–6013
Chen P-J, Hu S-H, Fan C-T, Li M-L, Chen Y-Y, Chen S-Y, Liu D-M (2013a) A novel multifunctional nano-platform with enhanced anti-cancer and photoacoustic imaging modalities using gold-nanorod-filled silica nanobeads. Chem Commun 49(9):892–894
Chen R, Zheng X, Qian H, Wang X, Wang J, Jiang X (2013b) Combined near-IR photothermal therapy and chemotherapy using gold-nanorod/chitosan hybrid nanospheres to enhance the antitumor effect. Biomater Sci 3:285–293
Chu Z, Yin C, Zhang S, Lin G, Li Q (2013) Surface plasmon enhanced drug efficacy using core shell Au@SiO2 nanoparticle carrier. Nanoscale 5:3406–3411
Dreaden EC, El-Sayed MA (2012) Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Acc Chem Res 45:1854–1865
Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA (2012a) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41:2740–2779. doi:10.1039/c1cs15237h
Dreaden EC, Mwakwari SC, Austin LA, Kieffer MJ, Oyelere AK, El-Sayed MA (2012b) Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells. Small 8:2819–2822
Durr NJ, Larson T, Smith DK, Korgel BA, Sokolov K, Ben-Yakar A (2007) Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett 7(4):941–945
Gorelikov I, Matsuura N (2008) Single-step coating of mesoporous silica on cetyltrimethyl ammonium bromide-capped nanoparticles. Nano Lett 8(1):369–373
Grzelczak M, Mezzasalma SA, Ni W, Herasimenka Y, Feruglio L, Montini T, Pérez-Juste J, Fornasiero P, Prato M, Liz-Marzán LM (2011) Antibonding plasmon modes in colloidal gold nanorod clusters. Langmuir 28(24):8826–8833
Gui C, Cui D-X (2012) Functionalized gold nanorods for tumor imaging and targeted therapy. Cancer Biol Med 9(4):221–233
He W, Liu Y, Yuan J, Yin J-J, Wu X, Hu X, Zhang K, Liu J, Chen C, Ji Y (2011) Au@Pt nanostructures as oxidase and peroxidase mimetics for use in immunoassays. Biomaterials 32(4):1139–1147
Hu C, Rong J, Cui J, Yang Y, Yang L, Wang Y, Liu Y (2012) Fabrication of a graphene oxide-gold nanorod hybrid material by electrostatic self-assembly for surface-enhanced raman scattering. Carbon 51:255–264
Hu B, Zhang L-P, Chen X-W, Wang J-H (2013) Gold nanorod-covered kanamycin-loaded hollow SiO2 (HSKAurod) nanocapsules for drug delivery and photothermal therapy on bacteria. Nanoscale 5(1):246–252
Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128(6):2115–2120
Huang X, Peng X, Wang Y, Wang Y, Shin DM, El-Sayed MA, Nie S (2010) A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4(10):5887–5896
Huang P, Bao L, Zhang C, Lin J, Luo T, Yang D, He M, Li Z, Gao G, Gao B (2011) Folic acid-conjugated Silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 32(36):9796–9809
Jokerst JV, Thangaraj M, Kempen PJ, Sinclair R, Gambhir SS (2012) Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods. ACS Nano 6(7):5920–5930
Ju H, Roy RA, Murray TW (2013) Gold nanoparticle targeted photoacoustic cavitation for potential deep tissue imaging and therapy. Biomed Opt Express 4(1):66–76
Jung Y, Reif R, Zeng Y, Wang RK (2011) Three-dimensional high-resolution imaging of gold nanorods uptake in sentinel lymph nodes. Nano Lett 11(7):2938–2943
Kah JCY, Chen J, Zubieta A, Hamad-Schifferli K (2012) Exploiting the protein corona around gold nanorods for loading and triggered release. ACS Nano 6(8):6730–6740. doi:10.1021/nn301389c
Kawano T, Niidome Y, Mori T, Katayama Y, Niidome T (2009) PNIPAM gel-coated gold nanorods for targeted delivery responding to a near-infrared laser. Bioconjug Chem 20(2):209–212
Kim D-H, Viventi J, Amsden JJ, Xiao J, Vigeland L, Kim Y-S, Blanco JA, Panilaitis B, Frechette ES, Contreras D (2010) Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics. Nat Mater 9(6):511–517
Kim CS, Tonga GY, Solfiell D, Rotello VM (2012) Inorganic nanosystems for therapeutic delivery: status and prospects. Adv Drug Deliv Rev 65:93–99
Kim ST, Saha K, Kim C, Rotello VM (2013) The role of surface functionality in determining nanoparticle cytotoxicity. Acc Chem Res 46(3):681–691
Komathi S, Gopalan AI, Kim S-K, Anand GS, Lee K-P (2013) Fabrication of horseradish peroxidase immobilized poly (N-[3-(trimethoxy silyl) propyl] aniline) gold nanorods film modified electrode and electrochemical hydrogen peroxide sensing. Electrochim Acta 92:71–78. doi:10.1016/j.electacta.2013.01.032
le Tuyen D, Liu AC, Huang CC, Tsai PC, Lin JH, Wu CW, Chau LK, Yang TS, le Minh Q, Kan HC, Hsu CC (2012) Doubly resonant surface-enhanced Raman scattering on gold nanorod decorated inverse opal photonic crystals. Opt Express 20(28):29266–29275. doi:10.1364/OE.20.029266
Leung JP, Wu S, Chou KC, Signorell R (2013) Investigation of sub-100 nm gold nanoparticles for laser-induced thermotherapy of cancer. Nanomaterials 3(1):86–106. doi:10.3390/nano3010086
Li YF, Chen C, Qu Y, Gao Y, Li B, Zhao Y, Chai Z (2008) Metallomics, elementomics, and analytical techniques. Pure Appl Chem 80(12):2577–2594
Lohse SE, Murphy CJ (2013) The quest for shape control: a history of gold nanorod synthesis. Chem Mater 25(8):1250–1261
Lozano N, Al-Jamal WT, Taruttis A, Beziere N, Burton NC, Van den Bossche J, Mazza M, Herzog E, Ntziachristos V, Kostarelos K (2012) Liposome-gold nanorod hybrids for high-resolution visualization deep in tissues. J Am Chem Soc 134(32):13256–13258. doi:10.1021/ja304499q
Lu G, Hou L, Zhang T, Liu J, Shen H, Luo C, Gong Q (2012) Plasmonic sensing via photoluminescence of individual gold nanorod. J Phys Chem C 116(48):25509–25516
Luo T, Huang P, Gao G, Shen G, Fu S, Cui D, Zhou C, Ren Q (2011) Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode X-ray CT and NIR fluorescence imaging. Opt Express 19(18):17030–17039
Mahajan SD, Aalinkeel R, Reynolds JL, Nair B, Sykes DE, Bonoiu A, Roy I, Yong KT, Law WC, Bergey EJ, Prasad PN, Schwartz SA (2012) Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex. Immunol Investig 41(4):337–355. doi:10.3109/08820139.2011.604863
Min Y, Mao C, Xu D, Wang J, Liu Y (2010) Gold nanorods for platinum based prodrug delivery. Chem Commun 46(44):8424–8426
Min Y, Mao C, Chen S, Ma G, Wang J, Liu Y (2012) Combating the drug resistance of cisplatin using a platinum prodrug based delivery system. Angew Chem Int Ed 51(27):6742–6747. doi:10.1002/anie.201201562
Ng VW, Berti R, Lesage F, Kakkar A (2013) Gold: a versatile tool for in vivo imaging. J Mater Chem B 1(1):9–25
Osberg KD, Rycenga M, Harris N, Schmucker AL, Langille MR, Schatz GC, Mirkin CA (2012) Dispersible gold nanorod dimers with sub-5 nm gaps as local amplifiers for surface-enhanced raman scattering. Nano Lett 12(7):3828–3832
Oyelere AK, Chen PC, Huang X, El-Sayed IH, El-Sayed MA (2007) Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug Chem 18(5):1490–1497
Qiu Y, Liu Y, Wang L, Xu L, Bai R, Ji Y, Wu X, Zhao Y, Li Y, Chen C (2010) Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31(30):7606–7619
Ramos J, Rege K (2012) Transgene delivery using poly(amino ether)-gold nanorod assemblies. Biotechnol Bioeng 109(5):1336–1346. doi:10.1002/bit.24408
Ren F, Bhana S, Norman DD, Johnson J, Xu L, Baker DL, Parrill AL, Huang X (2013) Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjug Chem 24:376–386
Shen S, Tang H, Zhang X, Ren J, Pang Z, Wang D, Gao H, Qian Y, Jiang X, Yang W (2013) Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 34(12):3150–3158. doi:10.1016/j.biomaterials.2013.01.051
Sivashanmugan K, Liao J-D, You J-W, Wu C-L (2013) Focused-ion-beam-fabricated Au/Ag multilayered nanorod array as SERS-active substrate for virus strain detection. Sens Actuators B Chem 361–367. doi:10.1016/j.snb.2013.01.035
Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60(11):1278–1288
Spadavecchia J, Barras A, Lyskawa J, Woisel P, Laure W, Pradier C-M, Boukherroub R, Szunerits S (2013) A novel approach for plasmonic based DNA sensing: amplification of the wavelength shift and simultaneous detection of the plasmon modes of gold nanostructures. Anal Chem 85:3288–3296
Sun Z, Deng L, Gan H, Shen R, Yang M, Zhang Y (2012) Sensitive immunosensor for tumor necrosis factor α based on dual signal amplification of ferrocene modified self-assembled peptide nanowire and glucose oxidase functionalized gold nanorod. Biosens Bioelectron 39:215–219
Truong PL, Kim BW, Sim SJ (2012) Rational aspect ratio and suitable antibody coverage of gold nanorod for ultra-sensitive detection of a cancer biomarker. Lab Chip 12(6):1102–1109. doi:10.1039/c2lc20588b
Tucker-Schwartz JM, Meyer TA, Patil CA, Duvall CL, Skala MC (2012) In vivo photothermal optical coherence tomography of gold nanorod contrast agents. Biomed Opt Express 3(11):2881–2895. doi:10.1364/BOE.3.002881
Van Noort J, van den Broek B, Ashcroft BA, Oosterkamp TH (2013) Parallel nanometric 3D tracking of intracellular gold nanorods using multifocal two-photon microscopy. Nano Lett 13:980–986
Vigderman L, Zubarev ER (2012) Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv Drug Deliv Rev 65:663–676
Vigderman L, Manna P, Zubarev ER (2012) Quantitative replacement of cetyl trimethylammonium bromide by cationic thiol ligands on the surface of gold nanorods and their extremely large uptake by cancer cells. Angew Chem Int Ed 124(3):660–665
Walkey CD, Olsen JB, Guo H, Emili A, Chan WC (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134(4):2139–2147
Wang H, Huff TB, Zweifel DA, He W, Low PS, Wei A, Cheng J-X (2005) In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc Natl Acad Sci USA 102(44):15752–15756
Wang C, Chen J, Talavage T, Irudayaraj J (2009) Gold nanorod/Fe3O4 nanoparticle “nano-pearl-necklaces” for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. Angew Chem Int Ed 121(15):2797–2801
Wang L, Liu Y, Li W, Jiang X, Ji Y, Wu X, Xu L, Qiu Y, Zhao K, Wei T (2010a) Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 11(2):772–780
Wang L, Zhu Y, Xu L, Chen W, Kuang H, Liu L, Agarwal A, Xu C, Kotov NA (2010b) Side-by-side and end-to-end gold nanorod assemblies for environmental toxin sensing. Angew Chem Int Ed 49(32):5472–5475
Wang P-H, Liu H-L, Hsu P-H, Lin C-Y, Wang C-RC, Chen P-Y, Wei K-C, Yen T-C, Li M-L (2012) Gold-nanorod contrast-enhanced photoacoustic micro-imaging of focused-ultrasound induced blood–brain-barrier opening in a rat model. J Biomed Opt 17(6):061221–061225
Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K (2008) Selective release of multiple DNA oligonucleotides from gold nanorods. J Am Chem Soc 3(1):80–86
Willets KA (2009) Surface-enhanced Raman scattering (SERS) for probing internal cellular structure and dynamics. Anal Bioanal Chem 394(1):85–94
Xiao Y, Hong H, Matson VZ, Javadi A, Xu W, Yang Y, Zhang Y, Engle JW, Nickles RJ, Cai W (2012a) Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics 2(8):757–768
Xiao Z, Ji C, Shi J, Pridgen EM, Frieder J, Wu J, Farokhzad OC (2012b) DNA self-assembly of targeted near-infrared-responsive gold nanoparticles for cancer thermo-chemotherapy. Angew Chem Int Ed 124(47):12023–12027
Xu L, Liu Y, Chen Z, Li W, Liu Y, Wang L, Liu Y, Wu X, Ji Y, Zhao Y, Ma L, Shao Y, Chen C (2012) Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment. Nano Lett 12(4):2003–2012. doi:10.1021/nl300027p
Yamashita S, Fukushima H, Akiyama Y, Niidome Y, Mori T, Katayama Y, Niidome T (2011) Controlled-release system of single-stranded DNA triggered by the photothermal effect of gold nanorods and its in vivo application. Bioorg Med Chem 19(7):2130–2135
Yang S, Ye F, Xing D (2012) Intracellular label-free gold nanorods imaging with photoacoustic microscopy. Opt Express 20(9):10370–10375
Yi DK, Sun I-C, Ryu JH, Koo H, Park CW, Youn I-C, Choi K, Kwon IC, Kim K, Ahn C-H (2010) Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer. Bioconjug Chem 21(12):2173–2177
Zhang Z, Wang L, Wang J, Jiang X, Li X, Hu Z, Ji Y, Wu X, Chen C (2012) Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 24(11):1418–1423. doi:10.1002/adma.201104714
Zhang J, Sun Y, Xu B, Zhang H, Gao Y, Zhang H, Song D (2013a) A novel surface plasmon resonance biosensor based on graphene oxide decorated with gold nanorod-antibody conjugates for determination of transferrin. Biosens Bioelectron 45:230–236. doi:10.1016/j.bios.2013.02.008
Zhang Y, Qian J, Wang D, Wang Y, He S (2013b) Multifunctional gold nanorods with ultrahigh stability and tunability for in vivo fluorescence imaging, SERS detection, and photodynamic therapy. Angew Chem Int Ed 52(4):1148–1151
Zhou X, Andoy NM, Liu G, Choudhary E, Han K-S, Shen H, Chen P (2012) Quantitative super-resolution imaging uncovers reactivity patterns on single nanocatalysts. Nat Nanotechnol 7(4):237–241
Zhu M, Nie G, Meng H, Xia T, Nel A, Zhao Y (2012a) Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res 46:622–630. doi:10.1021/ar300031y
Zhu Y, Kuang H, Xu L, Ma W, Peng C, Hua Y, Wang L, Xu C (2012b) Gold nanorod assembly based approach to toxin detection by SERS. J Mater Chem 22(6):2387–2391
Zhu J, Li J-j, Zhao J-w (2013) Optimizing the plasmonic sensing of RNA folding based on local refractive index change of gold nanorod. Appl Surf Sci 275:264–268. doi:10.1016/j.apsusc.2012.12.111
Author information
Authors and Affiliations
Corresponding author
Additional information
Xin Wang and Mingqian Shao contributed equally to this study.
Rights and permissions
About this article
Cite this article
Wang, X., Shao, M., Zhang, S. et al. Biomedical applications of gold nanorod-based multifunctional nano-carriers. J Nanopart Res 15, 1892 (2013). https://doi.org/10.1007/s11051-013-1892-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-013-1892-y